Sgen stock alert: halper sadeh llc is investigating whether the sale of seagen inc. is fair to shareholders

New york--(business wire)--halper sadeh llc, an investor rights law firm, is investigating whether the sale of seagen inc. (nasdaq: sgen) to pfizer inc. for $229.00 in cash per share is fair to seagen shareholders. halper sadeh encourages seagen shareholders to click here to learn more about their legal rights and options or contact daniel sadeh or zachary halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.
SGEN Ratings Summary
SGEN Quant Ranking